Skip to main content
. 2016 Jan;26(1):12–19. doi: 10.1016/j.numecd.2015.07.008

Table 1.

Baseline characteristics according to sodium levels (mEqu/L) in 3099 men with no diagnosed CHD, stroke or heart failure.

Sodium (mEq/L)
<136 (N = 207) 136-138 (N = 698) 139-143 (N = 2029) 144 (N = 109) ≥145 (N = 56) P overall difference
Age (yrs) 69.8 (5.53) 68.6 (5.47) 68.0 (5.35) 68.6 (5.47) 68.2 (5.74) <0.0001
% current smokers 18.0 14.9 12.2 10.2 7.3 0.04
% active 13.9 8.6 5.2 12.3 3.9 0.02
% manual 54.6 58.3 51.4 48.6 53.1 0.02
% moderate/heavy drinkers 22.7 19.5 19.3 9.2 12.5 0.03
% diabetes 15.9 16.2 7.8 15.9 8.9 <0.0001
% cancer 3.9 6.5 5.6 1.9 1.8 P = 0.19
% antihypertensive drugs 30.4 23.2 23.3 19.3 23.2 0.15
% diuretics 10.5 8.1 5.7 4.7 7.6 0.03
% statins 1.9 1.3 2.5 1.8 1.8 0.43
BMI (kg/m2) 25.8 (3.52) 26.8 (3.76) 26.8 (3.46) 27.4 (3.95) 27.1 (3.14) 0.001
Muscle mass (kg) 25.5 (2.51) 26.2 (2.29) 26.6 (2.33) 26.7 (2.13) 28.9 (2.29) <0.0001
SBP (mmHg) 151.3 (23.8) 149.0 (22.6) 150.4 (24.1) 148.5 (24.3) 156.6 (25.1) 0.14
Cholesterol (mmol/l) 5.89 (1.14) 6.15 (1.06) 6.07 (1.05) 6.13 (1.03) 5.90 (1.26) 0.02
HDL-C (mmol/l) 1.38 (0.35) 1.35 (0.37) 1.33 (0.34) 1.32 (0.29) 1.27 (0.31) 0.11
Glucose*(mmol/l) 6.23 (5.26–6.25) 6.05 (5.31–6.29) 5.70 (5.24–6.02) 5.64 (5.20–5.89) 5.75 (5.17–5.79) <0.0001
FEV1 (L) 2.40 (0.73) 2.60 (0.66) 2.67 (0.65) 2.54 (0.56) 2.68 (0.69) <0.0001
CRP*(mg/L) 2.24 (0.88–5.55) 1.73 (0.78–3.59) 1.57 (0.78–3.09) 1.72 (0.89–3.75) 1.36 (0.70–2.85) <0.0001
eGFR(ml/min per 1.73 m2) 76.1 (11.6) 73.4 (12.3) 72.7 (12.2) 69.1 (11.0) 73.5 (21.8) <0.0001
NT-proBNP 109.9 (52–205) 81.5 (41–154) 80.6 (40–147) 90.0 (42–182) 93.7 (50–202) 0.004
ALP 86.5 (71–108) 79.8 (66–94) 80.6 (68–94) 85.6 (67–99) 83.1 (69–95) 0.006
GGT 33.1 (20–44) 28.8 (19–38) 27.7 (19–38) 27.1 (19–38) 27.7 (18–32) 0.0007
Blood urea 5.52 (1.52) 5.88 (1.73) 5.98 (1.51) 5.89 (1.26) 6.17 (1.42) 0.001

Mean and SD; * geometric mean and interquartile range.